191 related articles for article (PubMed ID: 31020747)
1. Evaluation of wound fluid biomarkers to determine healing in adults with venous leg ulcers: A prospective study.
Stacey MC; Phillips SA; Farrokhyar F; Swaine JM
Wound Repair Regen; 2019 Sep; 27(5):509-518. PubMed ID: 31020747
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG; Martyn-St James M; Richardson R
Cochrane Database Syst Rev; 2013 Dec; (12):CD003557. PubMed ID: 24363048
[TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
4. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.
Drinkwater SL; Burnand KG; Ding R; Smith A
J Vasc Surg; 2003 Nov; 38(5):1106-12. PubMed ID: 14603223
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ovington LG
Cochrane Database Syst Rev; 2008 Jan; (1):CD003557. PubMed ID: 18254024
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG
Cochrane Database Syst Rev; 2010 Jan; (1):CD003557. PubMed ID: 20091548
[TBL] [Abstract][Full Text] [Related]
7. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status.
Wallace HJ; Stacey MC
J Invest Dermatol; 1998 Mar; 110(3):292-6. PubMed ID: 9506452
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
[TBL] [Abstract][Full Text] [Related]
9. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
10. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs.
Davies CE; Hill KE; Newcombe RG; Stephens P; Wilson MJ; Harding KG; Thomas DW
Wound Repair Regen; 2007; 15(1):17-22. PubMed ID: 17244315
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
13. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
14. Associations between patient, treatment, or wound-level factors and venous leg ulcer healing: Wound characteristics are the key factors in determining healing outcomes.
Weller CD; Bouguettaya A; Team V; Flegg J; Kasza J; Jayathilake C
Wound Repair Regen; 2020 Mar; 28(2):211-218. PubMed ID: 31642145
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of Skin Graft Healing in Venous Leg Ulcers.
Kirketerp-Møller K; Doerfler P; Schoefmann N; Wolff-Winiski B; Niazi O; Pless V; Karlsmark T; Ågren MS
Acta Derm Venereol; 2022 Jul; 102():adv00749. PubMed ID: 35604238
[TBL] [Abstract][Full Text] [Related]
16. Antiseptic with modern wound dressings in the treatment of venous leg ulcers: clinical and microbiological aspects.
Sopata M; Kucharzewski M; Tomaszewska E
J Wound Care; 2016 Aug; 25(8):419-26. PubMed ID: 27523653
[TBL] [Abstract][Full Text] [Related]
17. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study.
Lullove EJ
Wounds; 2017 Apr; 29(4):107-114. PubMed ID: 28448264
[TBL] [Abstract][Full Text] [Related]
18. Expected outcomes from topical haemoglobin spray in non-healing and worsening venous leg ulcers.
Arenberger P; Elg F; Petyt J; Cutting K
J Wound Care; 2015 May; 24(5):228, 230-2, 236. PubMed ID: 25970759
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings.
Hämmerle G; Strohal R
Int Wound J; 2016 Apr; 13(2):182-8. PubMed ID: 24589044
[TBL] [Abstract][Full Text] [Related]
20. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
